Lexaria Bioscience Corp (NQ: LEXX )Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
November 25, 2024
Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
November 14, 2024
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
November 07, 2024
Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
October 09, 2024
Lexaria Updates Current GLP-1 Market
October 08, 2024
Lexaria Appoints Michael Shankman as Chief Financial Officer
October 01, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|